Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 810 results for "bristol myers squibb"

Bristol-Myers Squibb partners with Five Prime on immunotherapy combination trials24-11-2014
Pharma Letter

Bristol-Myers, Five Prime Therapeutics Enter Into Clinical Col...

Bristol-Myers Squibb Co. (BMY: Quote) and Five Prime Therapeutics, Inc. (FPRX: Quote) announced that they have entered into an exclusive clinical collaboration agreement to evaluate the safety, tolerability and preliminary efficacy of combining ... RTTNews.com, 1 day ago
Six tumors on the FivePrime and BMS hit list Drug Discovery News, 20 hours ago
[x]  

101 images for bristol myers squibb

Philanthropy News Digest, 1 week ago
Irish Times, 1 week ago
Silicon Republic, 1 week ago
Irish Times, 1 week ago
Jutia Group, 1 day ago
Irish Times, 1 week ago
Irish Independent, 1 week ago
Irish Times, 1 week ago
Pharma Letter, 1 day ago
Pharma Letter, 1 week ago

Bristol-Myers Squibb Shares Up 12.6% Since SmarTrend's Buy Recommendation (BMY)

SmarTrend identified an Uptrend for Bristol-Myers Squibb (NYSE:BMY) on October 22nd, 2014 at $51.99. In approximately 1 month, Bristol-Myers Squibb has returned 12.56% as of today's recent price
 Individual.com15 hours ago Bristol-Myers Squibb Up 12.7% Since SmarTrend Uptrend Call (BMY)  Individual.com1 week ago

BMS announces encouraging data from Phase IIIb rheumatoid arthritis analyses

Bristol-Myers Squibb Company, or BMS, has announced encouraging data from new sub-analyses of the Phase IIIb Assessing Very Early Rheumatoid arthritis Treatment, or AVERT, trial that investigated the use of Orencia plus methotrexate, or MTX, in ...
 Individual.com21 hours ago Portola, BMS and Pfizer announce encouraging data from Phase III bleeding study  Individual.com15 hours ago

Bristol Myers (BMY) Showing Resistance Near $59.83

Bristol-Myers Squibb Co (http://www.marketintelligencecenter.com/symbol/BMY"BMY) was selected by MarketIntelligenceCenter.comaEUR(TM)s trade-picking algorithms today after trading between $58.66 and $59.50 on Friday before closing at $58.80. A ...
 Individual.com1 day ago Bristol Myers (BMY) Trading Near $59.04 Resistance Level  Individual.com4 days ago Bristol Myers (BMY) Showing Bullish Technicals With Resistance At $58.44  Individual.com1 week ago Bristol Myers (BMY) Showing Support Near $58.01  Individual.com5 days ago

Five Prime in cancer drug deal with Bristol-Myers

Five Prime Therapeutics said Monday that it will study a cancer drug regimen that combines one of its drugs with a therapy developed by Bristol-Myers Squibb. Five Prime said it will get $30 million
 Yahoo! UK and Ireland1 day ago Another Cancer Drug Deal, It's Bristol-Myers Squibb This Time  Trefis13 hours ago Weekly Pharmaceutical Notes: Pfizer, Johnson & Johnson, Bristol-Myers Squibb And Roche  Trefis4 days ago Drug prices plus low reimbursements force cancer docs to sell out  FiercePharma1 day ago
[x]  

A Buy Recommendation From Absolute Valuation Model to Bristol-Myers Squibb

In this article, let's take a look at Bristol-Myers Squibb Company (BMY), a $97.54 billion market cap company that is a leading global drugmaker, with strengths in cardiovascular, anti-infective and anticancer therapeutics. Returning value Since ...
 Yahoo! Finance1 day ago
Forbes.com

Bristol-Myers Squibb (BMY) Approaches New Upside Target of $59.04

Shares of Bristol-Myers Squibb (NYSE:BMY) have bullishly opened above the pivot of $58.56 today and have reached the first resistance level of $58.82. Investors may be interested in a cross of the next upside pivot targets of $59.04
 Individual.com4 days ago Bristol-Myers Squibb Hits New 12-Month High at $59.50 (BMY)  Mideast Time3 days ago Bristol-Myers Squibb (BMY) Five Prime Therapeutics (FPRX) Enter Exclusive Collaboration Covering Opdivo  Wall Street Business Network1 day ago January 2017 Options Now Available For Bristol-Myers Squibb (BMY)  Town Hall1 week ago
[x]  

Hepatitis C: Phase III UNITY trials results

Bristol-Myers Squibb Company has announced late-breaking data from the UNITY Trial program investigating a 12-week regimen of its all-oral daclatasvir (DCV) TRIO regimen - a fixed-dose combination of daclatasvir with asunaprevir (ASV) and beclabuvir ...
 Medical News Today1 day ago Bristol-Myers announces favorable data from hepatitis C virus trial  Individual.com6 days ago Bristol Myers Squibb : Phase 3 UNITY Trials Demonstrate High Cure Rates for Investigational, All-Oral Daclatasvir TRIO Fixed-Dose Combination in Genotype 1 Hepatitis C...  4 Traders6 days ago Bristol-Myers Squibb Announces Addl. Data From AVERT Trial - Quick Facts  RTTNews.com1 week ago

California Supreme Court to consider appeal on Plavix plaintiffsvisit|article-5904859|river-44317-1col-hp-38|1

The state Supreme Court agreed Wednesday to take up an appeal by Bristol-Myers Squibb Co. on whether 575 non-California residents can join a lawsuit in San Francisco claiming they were harmed by the company's anticlotting drug Plavix. The suit ...
 San Francisco Chronicle4 days ago

ABLS inks partnership with Synergy Partners to advance biopharmaceutical innovations from US institutions

Allied-Bristol Life Sciences, LLC (ABLS), a biopharmaceutical enterprise jointly owned between Allied Minds and Bristol-Myers Squibb Company, announced that it formed a strategic partnership with Synergy Partners R&D Solutions, LLC. Synergy ...
 PharmaBiz6 days ago Allied-Bristol Life Sciences Forms Strategic Partnership with Synergy Partners R&D Solutions to Advance Biopharmaceutical Innovations From Leading U.S. Academic Research Institutions  CNBC1 week ago Allied-Bristol Life Sciences, Synergy Partners Forge R&D Pact  Contract Pharma1 week ago Allied Minds : -Bristol Life Sciences Forms Strategic Partnership with Synergy Partners R%7ED Solutions To Advance Biopharmaceutical Innovations From Leading...  4 Traders6 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less